Tuesday - October 20, 2026

Axial Spondyloarthritis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2034 – DelveInsight | Janssen Pharma, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharma

The Key Axial Spondyloarthritis Companies in the market include – Janssen Pharmaceuticals, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, … Continue reading →

Triple Negative Breast Cancer Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | ModernaTX, Inc., OncoTherapy Science, Phoenix Molecular Designs

(Albany, New York) – October 20, 2026: As per DelveInsight’s assessment, globally, Triple Negative Breast Cancer pipeline constitutes 165+ key companies continuously working towards developing 170+ Triple Negative Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, … Continue reading →

North American Research Grade Peptide Supplier Volta Peptides Launches $10,000 USD Science Scholarship for Undergraduate Students in Canada and the United States

Volta Peptides announces its $10,000 USD Science Scholarship for undergraduate students in Canada and the United States, supporting education in chemistry, biochemistry, biotechnology, and related scientific disciplines. The Volta Peptides Science Scholarship will award $10,000 USD to an undergraduate student … Continue reading →